Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
暂无分享,去创建一个
T. Stockner | F. Wrba | E. Bajna | R. Horvat | E. Jensen‐Jarolim | J. Thalhammer | J. Singer | D. Mechtcheriakova | M. Willmann | Yury Sobanov | M. Weichselbaumer